Suppression of the mitochondrial oxidation of (-)-palmitylcarnitine by the malate-aspartate and alpha-glycerophosphate shuttles
- PMID: 1245472
Suppression of the mitochondrial oxidation of (-)-palmitylcarnitine by the malate-aspartate and alpha-glycerophosphate shuttles
Abstract
Palmitylcarnitine oxidation by isolated liver mitochondria has been used to investigate the interaction of fatty acid oxidation with malate, glutamate, succinate, and the malate-aspartate shuttle. Mitochondria preincubated with fluorocitrate were added to a medium containing 2mM ATP and ATPase. This system, characterized by a high energy change, allowed titration of respiration to any desired rate between States 4 and 3 (Chance, B., and Williams, G. R. (1956) Adv. Enzymol. Relat. Areas Mol. Biol. 17, 65-134). When respiration (reference, with palmitylcarnitine and malate as substrates) was set at 75% of State 3, the oxidation of palmitylcarnitine was limited by acetoacetate formation. The addition of malate or glutamate approximately doubled the rate of beta oxidation. Malate circumvented this limitation by citrate formation, but the effect of glutamate apparently was due to enhancement of the capacity for ketogenesis. The rate of beta oxidation was curtailed when malate and glutamate were both present. This curtailment was more pronounced when the malate-aspartate shuttle was fully reconstituted. Among the oxidizable substrates examined, succinate was most effective in inhibiting palmitylcarnitine oxidation. Mitochondrial NADH/NAD+ ratios were correlated positively with suppression of beta oxidation. The degree of suppression of beta oxidation by the malate-aspartate shuttle (NADH oxidation) or by succinate oxidation was dependent on the respiratory state. Both substrates extensively reduced mitochondrial NAD+ and markedly suppressed beta oxidation as respiration approached State 4. Calculations of the rates of flux of hydrogen equivalents through beta oxidation show that the suppression of beta oxidation by glutamate or by the malate-aspartate shuttle is accounted for by increased flux of reducing equivalents through mitochondrial malic dehydrogenase. This increased Flux is accompanied by an increase in the steady state NADH/NAD+ ratio and a marked decrease in the synthesis of citrate. The alpha-glycerophosphate shuttle was reconstituted with mitochondria isolated from rats treated with L-thyroxine. This shuttle was about equal to the reconstructed malate-aspartate shuttle in supression of palmitylcarnitine oxidation. This interaction could not be demonstrated in euthyroid animals owing to the low activity of the mitochondrial alpha-glycerol phosphate dehydrogenase. It is concluded that beta oxidation can be regulated by the NADH/NAD+ ratio. The observed stimulation of flux through malate dehydrogenase both by glutamate and by the malate-aspartate shuttle results in an increased steady state NADH/NAD+ ratio, and is linked to a stoichiometric outward transport of aspartate. We suggest, therefore, that some of the reducing pressure exerted by the malate-aspartate shuttle and by glutamate plus malate is provided through the energy-linked, electrogenic transport of aspartate out of the mitochondria. These results are discussed with respect to the mechanism of the genesis of ethanol-induced fatty liver.
Similar articles
-
Studies on the active transfer of reducing equivalents into mitochondria via the malate-aspartate shuttle.Biochim Biophys Acta. 1975 Mar 20;376(3):387-97. doi: 10.1016/0005-2728(75)90161-9. Biochim Biophys Acta. 1975. PMID: 164904
-
Operation and energy dependence of the reducing-equivalent shuttles during lactate metabolism by isolated hepatocytes.Biochim Biophys Acta. 1992 Sep 9;1136(3):223-30. doi: 10.1016/0167-4889(92)90110-w. Biochim Biophys Acta. 1992. PMID: 1520699
-
In vivo and in vitro adenosine stimulation of ethanol oxidation by hepatocytes, and the role of the malate-aspartate shuttle.Biochim Biophys Acta. 1987 Sep 14;930(2):254-63. doi: 10.1016/0167-4889(87)90038-3. Biochim Biophys Acta. 1987. PMID: 2887212
-
Neuronal and astrocytic shuttle mechanisms for cytosolic-mitochondrial transfer of reducing equivalents: current evidence and pharmacological tools.Biochem Pharmacol. 2006 Feb 14;71(4):399-407. doi: 10.1016/j.bcp.2005.10.011. Epub 2005 Dec 20. Biochem Pharmacol. 2006. PMID: 16368075 Review.
-
The malate-aspartate shuttle (Borst cycle): How it started and developed into a major metabolic pathway.IUBMB Life. 2020 Nov;72(11):2241-2259. doi: 10.1002/iub.2367. Epub 2020 Sep 11. IUBMB Life. 2020. PMID: 32916028 Free PMC article. Review.
Cited by
-
Mapping metabolic changes by noninvasive, multiparametric, high-resolution imaging using endogenous contrast.Sci Adv. 2018 Mar 7;4(3):eaap9302. doi: 10.1126/sciadv.aap9302. eCollection 2018 Mar. Sci Adv. 2018. PMID: 29536043 Free PMC article.
-
Fasting induces hepatic lipid accumulation by stimulating peroxisomal dicarboxylic acid oxidation.J Biol Chem. 2021 Jan-Jun;296:100622. doi: 10.1016/j.jbc.2021.100622. Epub 2021 Mar 31. J Biol Chem. 2021. PMID: 33811861 Free PMC article.
-
Pharmacological inhibition of fatty-acid oxidation synergistically enhances the effect of l-asparaginase in childhood ALL cells.Leukemia. 2016 Jan;30(1):209-18. doi: 10.1038/leu.2015.213. Epub 2015 Aug 4. Leukemia. 2016. PMID: 26239197
-
Insulin signaling meets mitochondria in metabolism.Trends Endocrinol Metab. 2010 Oct;21(10):589-98. doi: 10.1016/j.tem.2010.06.005. Epub 2010 Jul 16. Trends Endocrinol Metab. 2010. PMID: 20638297 Free PMC article. Review.
-
Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis.Mol Psychiatry. 2012 Mar;17(3):290-314. doi: 10.1038/mp.2010.136. Epub 2011 Jan 25. Mol Psychiatry. 2012. PMID: 21263444 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources